论文部分内容阅读
目的:探讨阿昔莫司联合普伐他汀应用于治疗老年高血脂血症的临床疗效。方法:对我院在2010年12月到2013年01月收治的100例老年高血脂血症患者随机分为治疗组和对照组,治疗组的患者使用阿昔莫司联合普伐他汀进行治疗,对照组的患者单独使用普伐他汀进行治疗。结果:治疗组患者临床疗效的总有效率为96%,对照组患者临床疗效的总有效率为88%,治疗组的临床疗效明显高于对照组患者(P<0.05);两组患者都没有出现较严重的不良反应。结论:阿昔莫司联合普伐他汀应用于治疗老年高血脂血症取得的临床疗效显著,值得在临床上广泛使用和推广。
Objective: To investigate the clinical efficacy of acipimox combined with pravastatin in the treatment of senile hyperlipidemia. Methods: A total of 100 elderly patients with hyperlipidemia admitted to our hospital from December 2010 to January 2013 were randomly divided into treatment group and control group. Patients in the treatment group were treated with acipimox combined with pravastatin, Patients in the control group were treated with pravastatin alone. Results: The total effective rate was 96% in the treatment group and 88% in the control group, and the clinical efficacy in the treatment group was significantly higher than that in the control group (P <0.05). There was no difference between the two groups More serious adverse reactions. Conclusion: The application of acipimox combined with pravastatin in the treatment of senile hyperlipidemia has obvious clinical curative effect, which is worth widely used and popularized in clinic.